PLx Pharma

About:

PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.

Website: http://www.plxpharma.com

Top Investors: Armentum Partners, Aurus, UT Horizon Fund, Integra Ventures, Emerald Private Equity Fund

Description:

PLx Pharma is a pharmaceutical company that develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing a molecular complex of ibuprofen and phosphatidylcholine.

Total Funding Amount:

$89.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2002-01-01

Contact Email:

ron.zimmerman(AT)plxpharma.com

Founders:

Lenard M. Lichtenberger, Ronald R. Zimmerman

Number of Employees:

11-50

Last Funding Date:

2021-03-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai